西梅纳菲尔在男性勃起功能障碍的有效性和安全性:多中心,随机,双盲,安慰剂控制,固定剂量,平行组,第三阶段试验
Yuzhuo Yang1, Xiansheng Zhang2, Tao Jiang3
1Department of Urology, Peking University First Hospital, Beijing, 100034, China.
The journal of sexual medicine
|July 8, 2025
概括
西梅纳菲尔有效治疗男性勃起功能障碍 (ED). 这项研究显示,与安慰剂相比,西梅纳菲尔在勃起功能和性接触成功方面显著改善,具有良好的安全性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 临床试验 临床试验
背景情况:
- 西梅纳菲尔是一种口服的固酶5型 (PDE5) 抑制剂,研究用于勃起功能障碍 (ED).
- PDE5 抑制剂是管理ED的关键治疗类.
研究的目的:
- 评估simenafil在治疗ED时的疗效和安全性.
- 为了确定在ED患者中西梅纳菲尔的最佳剂量.
主要方法:
- 一个多中心的,随机的,双盲的,安慰剂控制的,第三阶段研究.
- 765名ED男性接受了安慰剂或西梅纳菲尔 (2.5,5或10毫克) 按需治疗12周.
主要成果:
- 与安慰剂 (P <.001) 相比,西梅纳菲尔显著改善了勃起功能 (IIEF-EF评分) 和性接触成功 (SEP Q2,Q3).
- 药物不良反应轻度至中度,发生在36.2%的西梅纳菲尔接受者中,与安慰剂接受者的30.9%相比.
- 确定5毫克的剂量是临床推的,没有显著的PDE6或PDE11相关的不良事件.
结论:
- 西梅纳菲尔是一种高效且能耐受性勃起障碍的治疗选择.
- 该药物表现出良好的安全性和低有效剂量,提供了新的治疗选择.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
254
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
254
Disorders of the Male Reproductive System
592
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
592
Clinical Trials
8.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.6K
Male Sexual Response: Erection & Ejaculation
5.1K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
5.1K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Dose-Response Relationship: Potency and Efficacy
5.2K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.2K


